Indian company launches Remdesivir for treatment of COVID-19
Xinhua News,NEW DELHI
2020-08-13 16:05
Already collect
NEW DELHI, Aug. 13 (Xinhua) -- Zydus Cadila, an Indian pharmaceutical company, Thursday launched India's version of Remdesivir for treatment of COVID-19 patients.
The Remdesivir version will be sold under the brand name Remdac at a price of INR 2,800 (37.43 U.S. dollars).
Zydus is the fifth company to launch a version of antiviral in India.
Latest comments